Traders Blog - Analysis, Strategies, News and more: Tag - Stock Market

Gold and Dollar to Rise,  Stocks to Join as Election Day Gets Closer
Analysis

Gold and Dollar to Rise, Stocks to Join as Election Day Gets Closer

Political uncertainty is an additional factor traders have to cope with as neither former president Trump no Vice president Kamala Harris seem to have decisive lead over each other. Markets dynamics so far conform to historical patterns: volatil...

Author:
Andela Novotna
Published on: 31.10.2024 17:31 (UTC)
163
How BlackRock, Vanguard, and State Street Shape Corporate Governance
Analysis

How BlackRock, Vanguard, and State Street Shape Corporate Governance

In the modern financial landscape, few entities hold as much influence as BlackRock, Vanguard, and State Street. These three asset management giants are not only the largest institutional investors in the world, but they also wield extraordinary powe...

Author:
Mary Wild
Published on: 07.10.2024 10:06 (UTC)
644
Quality Stocks That Don’t Pay Dividends
Education

Quality Stocks That Don’t Pay Dividends

Quality stocks are stocks of companies that have strong fundamentals, such as high profitability, low debt, consistent earnings growth, and competitive advantage. Quality stocks are attractive for investors and traders because they tend to outperform...

Author:
Mary Wild
Published on: 12.03.2024 14:45 (UTC)
2360
Sony: Long-term outlook optimistic, but short-term concerns remain
Analysis

Sony: Long-term outlook optimistic, but short-term concerns remain

Sony`s operating profit jumped 10% in the third quarter, exceeding expectations thanks to strong performances in its financial services, movies, and music businesses. The Japanese tech giant also announced plans to list its financial unit, Sony Finan...

Author:
Mary Wild
Published on: 06.02.2024 16:39 (UTC)
1540
AbbVie's Big Buy of ImmunoGen Opens Doors for Potential Investment Gains
Analysis

AbbVie's Big Buy of ImmunoGen Opens Doors for Potential Investment Gains

In some major news dropped on Thursday, AbbVie, the big pharmaceutical player, has announced plans to snatch up ImmunoGen, a drugmaker, for a whopping $10.1 billion. This move is a game-changer for AbbVie, as it brings a promising ovarian cancer drug...

Author:
Mary Wild
Published on: 30.11.2023 18:12 (UTC)
996

Subscription

Subscribe to receive our latest news on your email.

Subscribe to receive our latest news on your email.